Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 86 Neoplasms 3 Osteoporosis 2 Neoplasm Metastasis 2 Lower Urinary Tract Symptoms 2 Hirsutism 2 Bulbo-Spinal Atrophy, X-Linked 2 Breast Neoplasms 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasms 1 Primary Dysautonomias 1 Ovarian Neoplasms 1 Kidney Diseases 1 Hypertension 1 Gynecomastia 1 Fallopian Tube Neoplasms 1 Erectile Dysfunction 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Adenocarcinoma 1

Interventions

bicalutamide 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Gynecomastia × bicalutamide × Clear all

NCT00637871 2011-01-24

Casodex - Nolvadex Combination

AstraZeneca

Phase 2 Completed

Gynecomastia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡